These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 20435197

  • 1. Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
    Buxbaum J, Alexander A, Koziol J, Tagoe C, Fox E, Kitzman D.
    Am Heart J; 2010 May; 159(5):864-70. PubMed ID: 20435197
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M.
    Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
    Agbor-Etang BB, Okafor HE, Farber-Eger EH, Wells QS.
    Am J Med; 2021 Feb; 134(2):e98-e100. PubMed ID: 32866461
    [Abstract] [Full Text] [Related]

  • 9. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM, Chaudhary K, Cho JH, Liang LW, Argulian E, Chan L, Dobbyn A, Guerraty MA, Judy R, Kay J, Kember RL, Levin MG, Saha A, Van Vleck T, Verma SS, Weaver J, Abul-Husn NS, Baras A, Chirinos JA, Drachman B, Kenny EE, Loos RJF, Narula J, Overton J, Reid J, Ritchie M, Sirugo G, Nadkarni G, Rader DJ, Do R.
    JAMA; 2019 Dec 10; 322(22):2191-2202. PubMed ID: 31821430
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant.
    Haring B, Hunt RP, Shadyab AH, Eaton C, Kaplan R, Martin LW, Panjrath G, Kuller LH, Assimes T, Kooperberg C, Wassertheil-Smoller S.
    JACC Heart Fail; 2023 Sep 10; 11(9):1189-1199. PubMed ID: 36930136
    [Abstract] [Full Text] [Related]

  • 11. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
    Ruberg FL, Maurer MS, Judge DP, Zeldenrust S, Skinner M, Kim AY, Falk RH, Cheung KN, Patel AR, Pano A, Packman J, Grogan DR.
    Am Heart J; 2012 Aug 10; 164(2):222-228.e1. PubMed ID: 22877808
    [Abstract] [Full Text] [Related]

  • 12. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL.
    JAMA Cardiol; 2017 Mar 01; 2(3):305-313. PubMed ID: 28196196
    [Abstract] [Full Text] [Related]

  • 13. Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans.
    Minamisawa M, Inciardi RM, Claggett B, Cuddy SAM, Quarta CC, Shah AM, Dorbala S, Falk RH, Matsushita K, Kitzman DW, Chen LY, Solomon SD.
    Eur J Heart Fail; 2021 Aug 01; 23(8):1290-1295. PubMed ID: 33928732
    [Abstract] [Full Text] [Related]

  • 14. The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa.
    Jacobson DR, Alexander AA, Tagoe C, Garvey WT, Williams SM, Tishkoff S, Modiano D, Sirima SB, Kalidi I, Toure A, Buxbaum JN.
    Mol Genet Genomic Med; 2016 Sep 01; 4(5):548-56. PubMed ID: 27652282
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.
    Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN.
    N Engl J Med; 1997 Feb 13; 336(7):466-73. PubMed ID: 9017939
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
    Madhani A, Sabogal N, Massillon D, Paul LD, Rodriguez C, Fine D, Helmke S, Winburn M, Kurian D, Raiszadeh F, Teruya S, Cohn E, Einstein AJ, Miller EJ, Connors LH, Maurer MS, Ruberg FL.
    J Am Heart Assoc; 2023 Aug 13; 12(15):e028973. PubMed ID: 37486082
    [Abstract] [Full Text] [Related]

  • 20. Transthyretin V122I in African Americans with congestive heart failure.
    Buxbaum J, Jacobson DR, Tagoe C, Alexander A, Kitzman DW, Greenberg B, Thaneemit-Chen S, Lavori P.
    J Am Coll Cardiol; 2006 Apr 18; 47(8):1724-5. PubMed ID: 16631014
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.